Safety and Tolerability of 619C89 after Acute Stroke

Publisher： Karger

E-ISSN： 1421-9786|8|1|31-37

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.8, Iss.1, 1998-01, pp. : 31-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Clinical Trial of Sipatrigine (619C89) by Continuous Infusion in Acute Stroke

By  

Cerebrovascular Diseases, Vol. 10, Iss. 6, 2000-10 ,pp. : 431-436

Karger

Access to resources Recommend Favorite

The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

By  

Cerebrovascular Diseases, Vol. 20, Iss. 5, 2005-11 ,pp. : 304-309

Karger

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of MCI-186 in Patients with Acute Ischemic Stroke: New Formulation and Dosing Regimen

By  

Cerebrovascular Diseases, Vol. 36, Iss. 3, 2013-10 ,pp. : 196-204

Karger

Access to resources Recommend Favorite

Xerostomia after Acute Stroke

By  

Cerebrovascular Diseases, Vol. 28, Iss. 6, 2009-10 ,pp. : 624-626

Karger

Access to resources Recommend Favorite

Safety and tolerability of abciximab in patients with acute miocardial infarction and failed thrombolysis

By Di Pasquale P.   Cannizzaro S.   Scalzo S.   Maringhini G.   Vitrano G.M.   Giubilato A.   Giambanco F.   Sarullo F.M.   Paterna S.  

International Journal of Cardiology, Vol. 92, Iss. 2, 2003-12 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite